Product Information
HYDROXYZINE 10 MG/5 ML SOLN is a generic product labeled by Bionpharma Inc., priced at $0.1132 per ML under NDC 69452039588. Its NADAC has been published 56 times since Sep 10, 2025.
FDA first approved this application on Apr 28, 2025. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
Bionpharma Inc.NDC
69452039588
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA219289FDA Approved
4/28/2025
TE Code
AA
On Market Since
7/17/2025
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE 10 MG/5 ML SOLN has been published 56 times since Sep 10, 2025, and over the history we have for it it has declined 35.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1132 per ML |
|---|---|
| All-time high | $0.1765 (Sep 10, 2025) |
| All-time low | $0.1089 (Aug 19, 2026) |
| 52-week high | $0.1609 |
| 52-week low | $0.1089 |
| Median price | $0.1282 |
| Average price | $0.1286 |
| Largest weekly change | -11.3% (Oct 22, 2025) |
| Weeks tracked | 56 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydroxyzine Hydrochloride Oral market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydroxyzine Hydrochloride Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROXYZINE 10 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE 10 MG/5 ML SOLN, manufactured by Bionpharma Inc., is $0.1132 per ML (NDC 69452039588), effective Sep 30, 2026.
How has the price of HYDROXYZINE 10 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE 10 MG/5 ML SOLN has declined 35.9%. It has been tracked across 56 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE 10 MG/5 ML SOLN?
Since Sep 10, 2025, the NADAC for HYDROXYZINE 10 MG/5 ML SOLN has ranged from a low of $0.1089 (Aug 19, 2026) to a high of $0.1765 (Sep 10, 2025), with a median of $0.1282 per ML.
Are there cheaper alternatives to HYDROXYZINE 10 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of HYDROXYZINE 10 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROXYZINE 10 MG/5 ML SOLN?
HYDROXYZINE 10 MG/5 ML SOLN (NDC 69452039588) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.